ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.131,97
0,32%
S&P 500
5.487,03
0,25%
Dow Jones
38.834,86
0,15%
Euro vs US Dollar
1,0739
-0,01%
Bitcoin
65.270,29
0,20%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Healthcare Capital Corporation (HCCCU)

  7. Healthcare Capital Corporation (HCCCU) News

HCCCU

Healthcare Capital (HCCCU)

Healthcare Capital Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:HCCCU
DatumZeitQuelleÜberschriftSymbolFirma
14/02/202321h38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HCCCUHealthcare Capital Corporation
08/03/202212h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HCCCUHealthcare Capital Corporation
07/03/202222h22Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:HCCCUHealthcare Capital Corporation
22/02/202222h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HCCCUHealthcare Capital Corporation
22/02/202213h30GlobeNewswire Inc.Healthcare Capital Corp. and Alpha Tau Medical Ltd. Announce Stockholder Approval of the Business CombinationNASDAQ:HCCCUHealthcare Capital Corporation
18/02/202222h17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:HCCCUHealthcare Capital Corporation
18/02/202219h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HCCCUHealthcare Capital Corporation
18/02/202217h38GlobeNewswire Inc.Healthcare Capital Corp. Announces Adjournment of Special Meeting of StockholdersNASDAQ:HCCCUHealthcare Capital Corporation
17/02/202216h11Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HCCCUHealthcare Capital Corporation
17/02/202216h10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HCCCUHealthcare Capital Corporation
15/02/202223h25Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HCCCUHealthcare Capital Corporation
15/02/202221h19GlobeNewswire Inc.Healthcare Capital Corp. Announces Adjournment of Special Meeting of StockholdersNASDAQ:HCCCUHealthcare Capital Corporation
14/02/202222h03Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:HCCCUHealthcare Capital Corporation
14/02/202220h28Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HCCCUHealthcare Capital Corporation
11/02/202222h05Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HCCCUHealthcare Capital Corporation
11/02/202220h41Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:HCCCUHealthcare Capital Corporation
04/02/202212h15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HCCCUHealthcare Capital Corporation
20/01/202212h45PR Newswire (US)Alpha Tau Announces New Research Collaboration to Study the Potential of Alpha DaRT to Enhance Immune Stimulation in the Treatment of Breast CancerNASDAQ:HCCCUHealthcare Capital Corporation
19/01/202222h08Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HCCCUHealthcare Capital Corporation
19/01/202222h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HCCCUHealthcare Capital Corporation
19/01/202213h40GlobeNewswire Inc.Healthcare Capital Corp Announces Special Meeting Date for Proposed Business Combination with Alpha Tau Medical Ltd.NASDAQ:HCCCUHealthcare Capital Corporation
14/01/202212h05Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:HCCCUHealthcare Capital Corporation
12/01/202223h13Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HCCCUHealthcare Capital Corporation
03/01/202213h00PR Newswire (US)Alpha Tau Announces Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck CancerNASDAQ:HCCCUHealthcare Capital Corporation
14/12/202122h29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HCCCUHealthcare Capital Corporation
15/11/202121h57Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HCCCUHealthcare Capital Corporation
17/08/202112h08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HCCCUHealthcare Capital Corporation
08/07/202119h13Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HCCCUHealthcare Capital Corporation
08/07/202119h01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HCCCUHealthcare Capital Corporation
08/07/202115h02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HCCCUHealthcare Capital Corporation
 Showing the most relevant articles for your search:NASDAQ:HCCCU

Kürzlich von Ihnen besucht

TSX
BNRE
Brookfield Reinsurance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten